BELLEROPHON THERAPEUTICS INC (BLPH) Stock Income Statement
NASDAQ:BLPH - Nasdaq - US0787713009 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.64M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 19.62M | 22.38M | 20.16M | 26.28M | 17.47M | |||
| Research and Development | 12.91M | 16.36M | 13.02M | 17.89M | 11.03M | |||
| Selling, General, and Administrative Expenses | 6.71M | 6.02M | 7.15M | 8.39M | 6.44M | |||
| Operating Income | -13.98M | -22.38M | -20.16M | -26.28M | -17.47M | |||
| Interest Income/Expense | 303.00K | 136.00K | 605.00K | -580.00K | 3.08M | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | -670.00K | |||
| Income Before Taxes | -13.68M | -22.25M | -19.56M | -26.85M | -15.07M | |||
| Income Tax | -1.28M | -2.42M | -1.80M | -2.13M | -1.80M | |||
| Net Income | -12.40M | -19.83M | -17.76M | -24.73M | -13.27M | |||
| EBITDA | -13.95M | -22.32M | -20.06M | -26.13M | -17.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.21 | -2.08 | -1.87 | -3.17 | -2.95 | |||
| Non GAAP EPS | -1.21 | -2.08 | -1.88 | -3.29 | -2.95 | |||
| Statistics | ||||||||
| Profit Margin | -219.88% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -247.89% | N/A | N/A | N/A | N/A | |||
All data in USD